NIH Launches Home Test to Treat, a Pilot COVID-19 Telehealth Program
NIH and ASPR, launch Home Test to Treat, a virtual health intervention to provide free COVID-19 health services in selected communities.
Tag: COVID-19 testing
All
Latest
All
Latest
How the ‘Test to Treat’ Initiative Aims to Get Ahead of the Next Wave of COVID-19
C. Michael White, a professor of pharmacy practice, and Adrian V. Hernandez, a clinical epidemiologist, both from the University of Connecticut, explain how the Biden administration’s new “test to treat” initiative will make use of pharmacies.
All
Latest
Barriers to COVID-19 Testing
Mild symptoms, poor knowledge of nearby testing sites, and certain demographic factors have been identified as barriers to COVID-19 testing.
Additional Authorization for Opti Medical SARS-CoV-2 Test
The Opti SARS-CoV-2 RT-PCR Test has received FDA Emergency Use Authorization and CE-IVD for sample handling using the OPTI Rapid Lysis Buffer.
Read More
Covid Testing Has Turned Into a Financial Windfall for Hospitals and Other Providers
Hospitals are charging up to $650 for a molecular covid test that costs $50 or less to run, according to Medicare claims analyzed by Hospital Pricing Specialists (HPS).
Read More
Backed by Millions in Public and Private Cash, Rapid COVID Tests Are Coming to Stores Near You
Scientists and lawmakers agree that over-the-counter COVID-19 tests could allow desk workers to settle back into their cubicles and make it easier to reopen schools and travel.
Read More
First SARS-CoV-2 Test Granted Marketing Authorization
The FDA granted marketing authorization to the BioFire Respiratory Panel 2.1, the first SARS-CoV-2 diagnostic test permitted to be marketed beyond the COVID-19 public health emergency.
Read More
New COVID Test Pooling Strategy Offers Early Outbreak Detection
Researchers have proposed a new quantitative strategy for pooling COVID-19 tests in order to monitor spread and detect outbreaks early within closed communities, such as nursing homes or universities.
Read More
FDA Authorizes First Molecular Non-Prescription, At-Home COVID-19 Test
The US FDA has issued an emergency use authorization (EUA) for the Cue COVID-19 Test for Home and Over The Counter Use.
Read More
SARS-CoV-2 Antibody Test Helps Select Donor Blood Samples for Therapeutic Use
A new COVID-19 antibody assay was able to detect IgG and IgM antibodies to determine viable donor samples for therapeutic use and clinical trials.
Read More
Entire UK Population to Be Home-Tested for COVID-19 Weekly
According to Spectrum Solutions, the company’s saliva-based COVID-19 home test will be rolled out to the United Kingdom as part of the country’s efforts to test its entire population, weekly.
Read More
Rheonix COVID-19 MDx Assay Receives Expanded FDA Emergency Use Authorization to Include Saliva as a Sample Type
Rheonix Inc received an expanded FDA emergency use authorization that allows the use of saliva as an approved sample type.
Read More
LabCorp’s Pixel COVID-19 Test Now Authorized Direct-to-Consumer
LabCorp’s Pixel COVID-19 Test Home Collection Kit has been authorized for emergency use by the FDA — the first COVID-19 direct-to-consumer (non-prescription) test system.
Read More
FDA Reauthorizes BinaxNow COVID-19 Test for Home Use
The US FDA issued a new emergency use authorization for Abbott’s BinaxNow COVID-19 Ag Card Home Test, which is now authorized for use by patients at home with a prescription.
Read More
Study to Evaluate $5, 10-min Saliva Test for COVID-19
Stanford Medicine is seeking volunteers for a study of an at-home, COVID-19 saliva test that’s designed to cost $5 or less, use no electricity and provide fast and accurate results.
Read More